Analyst consensus rating
Tenaya Therapeutics Analyst Rating: none
Direct answer
Tenaya Therapeutics's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.20.
Forecast evidence checked September 4, 2026.
Get free Tenaya Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.70
- Average price target
- $3.20
- High price target
- $5.00
- Low price target
- $2.00
- Low target gap
- +187.6%
- Target upside
- +360.2%
- High target gap
- +619.1%
- Target range width
- 431.5%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- September 4, 2026
- Valid through
- September 11, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Tenaya Therapeutics?
Tenaya Therapeutics has a verified none consensus. The same dataset has an average price target of $3.20.
How far are Tenaya Therapeutics's low and high targets from the recorded price?
The low target implies +187.6%, while the high target implies +619.1%.
How many analysts are included in Tenaya Therapeutics's consensus?
The verified consensus includes 5 analysts.
How is Tenaya Therapeutics's target upside or downside calculated?
The average target of $3.20 is divided by the recorded price of $0.70, then one is subtracted to produce +360.2%. This does not guarantee a future return.
When was Tenaya Therapeutics's analyst forecast verified?
The data was verified on 2026-09-04. The dataset is valid through 2026-09-11.